pharmanewsdaily
1509 posts
An egg a day might reduce risk of heart disease: Study
New Delhi, Jan 28 (ANI): A new study conducted in China finds that eating an egg a day…
January 28, 2019
Spectrum Pharmaceuticals to divest seven oncology drugs in $300m deal with Acrotech Biopharma
In a major strategic move, Spectrum Pharmaceuticals, a prominent US-based biopharma company, has entered into a deal with…
January 27, 2019
Heavy work pressure may be the reason for gaining weight
New Delhi, Jan 27 (ANI): According to a recent study, work pressures inclined women to weight gain. During…
January 27, 2019
X-Rx announces FDA acceptance of IND for X-165, a potential treatment for Idiopathic Pulmonary Fibrosis
US-based biotech company X-Rx has received a major boost in its quest to develop new treatments for Idiopathic…
January 26, 2019
Tamr partners with Accenture to tackle data challenges in drug discovery
Tamr Inc. has officially joined Accenture’s open partner ecosystem, a strategic collaboration designed to enhance efforts in drug…
January 26, 2019
Clovis Oncology secures EC approval for Rubraca’s new indication in ovarian cancer treatment
In a major win for Clovis Oncology, the European Commission (EC) has granted approval for an expanded indication…
January 26, 2019
Eusa Pharma completes $115m acquisition of Sylvant for iMCD treatment
Eusa Pharma has successfully acquired the global rights to Sylvant (siltuximab), a drug used in the treatment of…
January 20, 2019
Takeda’s $62bn acquisition of Shire: A game-changing move for global pharma
In a landmark deal, Takeda Pharmaceutical Company has successfully completed its previously announced acquisition of Shire, an Irish…
January 20, 2019
Lilly to acquire Loxo Oncology in $8bn deal: A game-changer in precision cancer treatment
Eli Lilly and Company (Lilly), a global leader in pharmaceuticals, has made headlines with its announcement to acquire…
January 13, 2019
Bristol-Myers Squibb to acquire Celgene in $74bn pharma megadeal
Bristol-Myers Squibb has reached a definitive agreement to acquire Celgene Corporation in a monumental cash-and-stock deal worth approximately…
January 6, 2019